Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients

Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients

Abstract Aims Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis. EBA concentration increases according to severity of HF and is associated with poor prognosis, especially in acute decompensated HF. However, there are no data on chronic HF patients. Th...

Full description

Bibliographic Details
Main Authors: Fabiana G. Marcondes‐Braga, Luciana Gioli‐Pereira, Sabrina Bernardez‐Pereira, Guilherme L. Batista, Sandrigo Mangini, Victor S. Issa, Fabio Fernandes, Edimar A. Bocchi, Silvia M. Ayub‐Ferreira, Alfredo J. Mansur, Ivano G.R. Gutz, Jose E. Krieger, Alexandre C. Pereira, Fernando Bacal
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:ESC Heart Failure
Subjects:
Heart failure
Exhaled breath acetone
Biomarker
Prognosis
Online Access:https://doi.org/10.1002/ehf2.12736

Internet

https://doi.org/10.1002/ehf2.12736

Similar Items